Hide Board Information

Show Board Information

Soleno Therapeutics, Inc. SLNOW

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/23/2017 1:35:43 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

CAPNW

Soleno Therapeutics, Inc. (NASDAQ: SLNOW) Stock Message Board

1. SLNOW Company Profile

    

2. SLNOW Time & Sales

    

3. SLNOW Recent News

    

4. SLNOW Filings

    

5. SLNOW Financials

    

6. SLNOW Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Soleno Therapeutics, Inc. SLNOW

Recent Articles

• Prosafe SE Reports Significant Shareholding Changes
• Chicago Atlantic BDC, Inc. Unveils Impressive Q3 2025 Results
• KP Tissue Unveils Quarterly Dividend of $0.18 for Shareholders
• Shell's Latest Prospectus Supplement Overview and Insights
• Dillard's, Inc. Sees Growth in Q3 Performance Metrics
• Carpenter Technology Shifts to Bull Market: Get the Latest Upgrades
• Immunic, Inc. Delivers Positive Q3 2025 Financial Outcomes
• Critical One Energy's Strategic Hire to Elevate Antimony-Gold Focus
• HLS Therapeutics Reports Strong Growth in Q3 2025 Results
• Alliance Creative Group Unveils Q3 Results and Future Growth Plans
• Brookfield Corporation Shines with Stellar Q3 Financial Performance
• Brookfield Wealth Solutions Shares Important Q3 Financials
• Pelthos Therapeutics Reports Strong Q3 2025 Performance Highlights
• Exploring Bilibili's Surge: Engagement and Revenue Growth
• Dillard's Inc Achieves Growth Amid Third Quarter Challenges
• Protalix BioTherapeutics Sees Revenue Growth and Future Potential
• Alliance Creative Group's Strategic Growth and Financial Insights
• Brookfield Wealth Solutions Reports Strong Third Quarter Gains
• Quhuo Strengthens International Trade with Blockchain Innovations
• Revolutionizing Haircare: Neutrogena® and OGX® Innovations
• Brightstar Lottery to Launch Innovative Instant Ticket Games
• Tradr Unveils New Leveraged ETFs Focused on Tech Innovations
• Protalix BioTherapeutics Shares Q3 2025 Financial Insights
• Duncan Regional Hospital Pioneers Infusion Technology with BD
• Pelthos Therapeutics Reports Strong Q3 2025 Performance
• Brookfield Corporation Delivers Impressive Third Quarter Growth
• Exploring the Timeless Lessons of Tiangong Kaiwu Culture
• Castellum, Inc. Achieves $2 Million Debt Elimination Milestone
• RecycLiCo Advances Growth Strategies at Global Conference
• Bitfarms Reveals Ambitious Transition to HPC and AI Workloads
• Day One Biopharmaceuticals Closes In on Strategic Acquisition
• EnviroGold Global's Phase 3 Results Showcase Remarkable Advances
• Day One Biopharmaceuticals to Acquire Mersana Therapeutics
• Exciting Innovations from Dassault Aviation at Airshow
• Apple's New Feature: Digital Passport on Your iPhone
• Strategic Growth: Americas Gold and Silver's Acquisition Plans
• Grab and WeRide Secure Approval for Innovative AV Testing
• Beacon Biosignals Secures $86M for Revolutionary AI Innovations
• Analyst Critiques Oracle's AI Strategy: A Risky Business Model
• Key Housing Announcement by Canadian Government Officials
• DarioHealth: Third Quarter Financial Overview and Insights
• BorgWarner Announces Quarterly Dividend for Shareholders
• EPWK Holdings Ltd. Implements Major Share Consolidation
• Immunic, Inc. Updates Financial Performance and Milestones
• DarioHealth Navigates Financial Landscape with Strategic Adjustments
• SUNMI Joins PCI SSC: Redefining Global Payment Security Standards
• U.S. Dermatology Partners Strengthens Network with New Texas Clinic
• AtkinsRéalis Sees Significant Growth in Q3 2025 Financials
• Harbinger Secures $160 Million in Series C Round Financing
• JD.com Celebrates User Milestone Amid Financial Challenges